An economic analysis of annual influenza vaccination of children

被引:67
|
作者
Meltzer, MI [1 ]
Neuzil, KA [1 ]
Griffin, MR [1 ]
Fukuda, K [1 ]
机构
[1] CDC, NCID, OD, OS, Atlanta, GA 30333 USA
关键词
influenza vaccination; economics; children; high risk;
D O I
10.1016/j.vaccine.2004.07.040
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We used a Monte Carlo mathematical model to calculate the net economic returns (cost-benefit analysis) from annually vaccinating children against influenza. The model included cohorts of 1000 children in three different age groups (6-23 months, 6-59 months, and 5-14 years), with different proportions of children with high risk conditions (100, 10, and 0%). Vaccinating cohorts of 100% high risk children in all three age groups produced median net savings, regardless of cost of vaccination examined (US$ 30-60/dose administered). Median threshold vaccination costs for cohorts containing 10% high risk children were US$ 48, 46, and 45 per dose administered for age groups 6-23 months, 6-59 months, and 5-14 years, respectively (US$/dose administered below these thresholds generate net savings). For all cohorts, for the range of cost per dose administered examined, the 5th percentiles were net costs. The probability of death, though rare, was the most influential distribution in the model. The number of high-risk children that receive influenza vaccine should be maximized to achieve improved health outcomes as well as cost savings. Published by Elsevier Ltd.
引用
收藏
页码:1004 / 1014
页数:11
相关论文
共 50 条
  • [1] Economic evidence of influenza vaccination in children
    Savidan, Emmanuelle
    Chevat, Catherine
    Marsh, Grenville
    HEALTH POLICY, 2008, 86 (2-3) : 142 - 152
  • [2] Economic impact of influenza vaccination in preschool children
    Cohen, GM
    Nettleman, MD
    PEDIATRICS, 2000, 106 (05) : 973 - 976
  • [3] Influenza vaccination in healthy children
    Bueving, Herman J.
    van der Wouden, Johannes C.
    VACCINE, 2006, 24 (23) : 4901 - 4901
  • [4] Physician perspectives regarding annual influenza vaccination among children with asthma
    Dombkowski, Kevin J.
    Leung, Sonia W.
    Clark, Sarah J.
    AMBULATORY PEDIATRICS, 2008, 8 (05) : 294 - 299
  • [5] Economic value of influenza vaccination
    de Waure, Chiara
    Veneziano, Maria Assunta
    Cadeddu, Chiara
    Capizzi, Silvio
    Specchia, Maria Lucia
    Capri, Stefano
    Ricciardi, Walter
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (01) : 119 - 129
  • [6] Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years
    Esposito, S
    Marchisio, P
    Bosis, S
    Lambertini, L
    Claut, L
    Faelli, N
    Bianchi, C
    Colombo, GL
    Principi, N
    VACCINE, 2006, 24 (05) : 629 - 635
  • [7] Universal influenza vaccination and live attenuated influenza vaccination of children
    Glezen, W. Paul
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2008, 27 (10) : S104 - S109
  • [8] Influenza vaccination in children with cancer receiving chemotherapy
    Esposito, Susanna
    Cecinati, Valerio
    Russo, Fabio Giovanni
    Principi, Nicola
    HUMAN VACCINES, 2009, 5 (06): : 430 - 432
  • [9] Expanding the Recommendations for Annual Influenza Vaccination to School-Age Children in the United States
    Fiore, Anthony E.
    Epperson, Scott
    Perrotta, Dennis
    Bernstein, Henry
    Neuzil, Kathleen
    PEDIATRICS, 2012, 129 : S54 - S62
  • [10] Influenza vaccination in healthy children
    Principi, Nicola
    Esposito, Susanna
    VACCINE, 2007, 25 (03) : 401 - 401